PCSA · Processa Pharmaceuticals, Inc. · Fails to Deliver
$1.81
-0.05 (-2.69%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“Following our acquisition of Vidya and closing of the related $200 million gross private placement (from which we received net proceeds of $183.3 million) on July 30, 2026, we believe our cash and cash equivalents will be sufficient to satisfy our cash requirements over the next 12 months and beyond. This represents a material change from what we reported in our 2025 Form 10-K that disclosed substantial doubt of our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.06M
Shares
2.79M
Volume · Oct 23
35.05K
Avg daily vol (3M)
266.29K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-22 | 2,140 | $1.84 | $3,938 |
| 2026-09-18 | 142 | $1.93 | $274 |
| 2026-09-15 | 51 | $1.91 | $97 |
| 2026-09-09 | 1,853 | $2.16 | $4,002 |
| 2026-09-04 | 400 | $2.05 | $820 |
| 2026-08-26 | 4 | $2.18 | $9 |
| 2026-08-25 | 1,711 | $2.17 | $3,713 |
| 2026-08-21 | 12 | $2.15 | $26 |
| 2026-08-13 | 1,933 | $2.56 | $4,948 |
| 2026-08-12 | 126 | $2.63 | $331 |
| 2026-08-10 | 6,165 | $2.57 | $15,844 |
| 2026-08-07 | 340 | $2.30 | $782 |
| 2026-08-06 | 1,640 | $2.19 | $3,592 |
| 2026-08-05 | 2,240 | $2.12 | $4,749 |
| 2026-08-04 | 502 | $2.13 | $1,069 |
| 2026-08-03 | 2,724 | $2.15 | $5,857 |
| 2026-07-31 | 15,144 | $2.04 | $30,894 |
| 2026-07-30 | 74,470 | $2.03 | $151,174 |
| 2026-07-29 | 3,143 | $3.05 | $9,586 |
| 2026-07-28 | 793 | $2.59 | $2,054 |
| 2026-07-27 | 2,226 | $2.60 | $5,788 |
Showing 1–21 of 21 settlements